| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them |
| 07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
| 07/13/1995 | WO1995018861A1 Influenza vaccine |
| 07/13/1995 | WO1995018860A1 Control of marek's disease by the inhibition of latency and tumor cell development |
| 07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | WO1995018852A1 Herpesvirus replication defective mutants |
| 07/13/1995 | WO1995018819A1 Ligand that binds fas antigen |
| 07/13/1995 | WO1995018815A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 07/13/1995 | WO1995018808A1 Cyclic polyamines |
| 07/13/1995 | WO1995018791A1 Pharmaceutical formulations comprising polythiourea and method of use thereof |
| 07/13/1995 | WO1995018633A1 Soft agar penetration-defective mutants |
| 07/13/1995 | WO1995011919A3 Recombinant pilc proteins, process for producing them and their use |
| 07/13/1995 | CA2180551A1 Herpesvirus replication defective mutants |
| 07/13/1995 | CA2180358A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/12/1995 | EP0662477A1 Heterobicyclic compounds with fungicidal activity |
| 07/12/1995 | EP0662157A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 07/12/1995 | EP0662139A1 Recombinant retroviral vector against felv and/or fiv |
| 07/12/1995 | EP0662133A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/12/1995 | EP0662132A1 Self-assembling recombinant papillomavirus capsid proteins |
| 07/12/1995 | EP0662128A1 Methods and compositions for controlling translation of hcv proteins |
| 07/12/1995 | EP0662092A1 Activity-dependent neurotrophic factor |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0662083A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 07/12/1995 | EP0661999A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 07/12/1995 | EP0661998A1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection |
| 07/12/1995 | EP0661974A1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin |
| 07/12/1995 | EP0661967A1 Combined virustatic antimediator (covam) treatment of common colds |
| 07/12/1995 | EP0661930A1 Viscous liquid xylitol compositions and method for preparing same |
| 07/11/1995 | US5432190 Pharmaceutical compositions containing triazoles and method of treating estrogen-dependent diseases |
| 07/11/1995 | US5432165 Methods for the treatment of infection caused by Hepatitis B virus (HBV) |
| 07/11/1995 | US5432157 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof |
| 07/11/1995 | US5431925 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 07/11/1995 | US5431902 New medicament aerosol formulation based on fusafungine |
| 07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| 07/11/1995 | CA1336262C Mycoplasma vaccine |
| 07/06/1995 | WO1995018231A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
| 07/06/1995 | WO1995018223A1 Gene expression control |
| 07/06/1995 | WO1995018148A1 T-cell epitopes |
| 07/06/1995 | WO1995018109A1 Novel antiviral 2,4-pyrimidinedione derivatives and processes for the preparation thereof |
| 07/06/1995 | WO1995018091A1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | WO1995017898A1 A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
| 07/06/1995 | WO1995012682A3 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 07/06/1995 | CA2179639A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
| 07/06/1995 | CA2155095A1 Unsaturate amino compounds for use as anticancer and antiprotozoic agent |
| 07/05/1995 | EP0661058A1 Use of bradykinin antagonists for the treatment of viral diseases |
| 07/05/1995 | EP0661055A1 Pharmaceutical formulation containing clobetasone and tobramycin and applications thereof |
| 07/05/1995 | EP0661036A1 Antiacne composition for the simultaneous treatment of superficial and lower layers of the skin |
| 07/05/1995 | EP0661028A1 Condom coated with acidic polysaccarides |
| 07/05/1995 | EP0660837A1 Penem derivatives, their preparation and pharmaceutical compositions containing them |
| 07/05/1995 | EP0660826A1 5,5-disubstituted hydantoins |
| 07/05/1995 | EP0660712A1 Transcutaneous in vivo activation of photosensitive agents in blood |
| 07/05/1995 | EP0660710A1 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 07/05/1995 | EP0660709A1 Creatine analogs having antiviral activity |
| 07/05/1995 | EP0660668A1 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 07/05/1995 | EP0328634B1 Pharmaceutical compositions for the treatment of psoriasis |
| 07/05/1995 | EP0309537B1 Process for the preparation of quinoline carboxylic acids |
| 07/05/1995 | CN1104641A Process for preparing N-tert-butylamides |
| 07/05/1995 | CN1029231C Triazole antifungal agents |
| 07/04/1995 | US5430162 7-(substituted)-8-(substituted)-9-substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/04/1995 | US5430151 Trifluoromethyl-containing pseudopeptides active against retroviruses |
| 07/04/1995 | US5430150 N-(1-(((1H-benzimidazol-2-ylmethyl)amino)carbonyl)-2-methyl -butyl)-3-(((1,1-dimethylethyl)amino)-carbonyl)decahydro-gamma-hydroxyalpha -(phenylmethyl)-2-isoquinolinepentanamide compounds; AIDS |
| 07/04/1995 | US5430148 Antiproliferative quinazolines |
| 07/04/1995 | US5430045 Administering an L-2-oxothiazolidine-4-carboxylate to patient receiving AZT |
| 07/04/1995 | US5430041 Amino acid derivatives having antiviral activity |
| 07/04/1995 | US5430026 2'-deoxy-2',2'-difluoro (4-substituted pyrimidine) nucleosides, bicyclic derivatives,pharmaceutical compositions, and synthetic precursors |
| 07/04/1995 | US5430018 Cyclohexapeptide with basic nitrogen containing alkylamide groups |
| 06/29/1995 | WO1995017677A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| 06/29/1995 | WO1995017511A2 Mycobacteria virulence factors and a method for their identification |
| 06/29/1995 | WO1995017503A1 Thermostable varicella zoster virus |
| 06/29/1995 | WO1995017423A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | WO1995017414A1 Anti-hepatitis b viral oligonucleotides |
| 06/29/1995 | WO1995017407A1 Tetrahydrofuran antifungals |
| 06/29/1995 | WO1995017390A1 N-substituted aryl trifluoromethyl imidazoles |
| 06/29/1995 | WO1995017190A1 Pharmaceuticals |
| 06/29/1995 | WO1995017184A1 Pharmaceutical compositions containing ceftriaxone and penems |
| 06/29/1995 | WO1995017092A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1¿η? |
| 06/29/1995 | WO1995014011A3 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| 06/29/1995 | CA2179772A1 Mycobacteria virulence factors and a method for their identification |
| 06/29/1995 | CA2179606A1 Macrophage inflammatory proteins-3, -4 and -1.gamma. |
| 06/29/1995 | CA2179597A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | CA2179282A1 Pharmaceuticals |
| 06/29/1995 | CA2179153A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
| 06/29/1995 | CA2178811A1 Anti-hepatitis b viral oligonucleotides |
| 06/29/1995 | CA2177060A1 Thermostable varicella zoster virus |
| 06/28/1995 | EP0659885A1 Vaccine against viruses associated with antibody-dependent-enhancement of viral infectivity |
| 06/28/1995 | EP0659752A1 Novel substance dc114-a1 |
| 06/28/1995 | EP0659436A1 A potentiator for interferon and an antiviral activity-potentiating composition containing interferon and its potentiator |
| 06/28/1995 | EP0659181A1 Sulfonamide inhibitors of hiv-aspartyl protease |
| 06/28/1995 | EP0659180A1 Anti-viral sulfur-analogues of 1,5-dideoxy-1,5-imino-d-glucitol (deoxynojirimycin) |
| 06/28/1995 | EP0659177A1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use |
| 06/28/1995 | EP0640095A4 Process for making vancomycin. |
| 06/28/1995 | EP0563256B1 Use of host cell phospholipids for inhibiting bacterial colonization |
| 06/28/1995 | EP0552280B1 Inhibition of viral replication |
| 06/28/1995 | EP0539405B1 Peptides and analogues and mixtures thereof for detecting antibodies to htlv-i and htlv-ii viruses |
| 06/28/1995 | EP0439540B1 Antibody conjugates with two or more covalently linked fc regions |
| 06/28/1995 | CN1104214A Novel 2-thiosubstituted carbapenems |
| 06/28/1995 | CN1104209A 2,4-diamino-3-hydroxycarboxylic acid derivatives |
| 06/28/1995 | CN1104112A Anal fistula eliminating medicine |